Enhance MD vs BreezeMeds: Semaglutide & Tirzepatide Pricing
Quick verdict: For the lowest introductory cost and a flat-rate pricing model, Enhance MD leads; for a broader product menu that includes oral GLP-1 options, BreezeMeds lists higher starting prices but more formats. This comparison of Enhance MD vs BreezeMeds focuses on pricing structure, product formats, transparency, and regulatory notes so you can decide quickly.
See Enhance MD starting prices
Enhance MD vs BreezeMeds: prices and pricing model
Enhance MD advertises semaglutide from $49 first month and tirzepatide from $99 first month, with a flat-rate pricing claim that the same price applies at every dose and no fee escalation during titration. BreezeMeds shows semaglutide injection from $199/mo and tirzepatide injection from $299, and oral semaglutide and oral tirzepatide displayed from $399. A separate $169 figure appears on BreezeMeds without a clear product association.
Direct comparison
Enhance MD: lowest first-month entry prices and explicit flat-rate pricing. BreezeMeds: higher starting figures and product-level prices that include injectable and oral formats, but some displayed offers lack clear product ties.
Product formats and compound availability
Both platforms offer semaglutide and tirzepatide in some form. Enhance MD highlights both semaglutide and tirzepatide on one platform with compounded formulations. BreezeMeds lists injectable semaglutide and tirzepatide and also displays oral semaglutide and oral tirzepatide options.
Transparency and terms
Enhance MD emphasizes flat-rate ongoing pricing and says there are no hidden fees as doses increase, but ongoing flat-rate prices are not always prominently published before intake. BreezeMeds promotes “Affordable Pricing” and discreet shipping but the landing evidence shows fees and billing commitments were not fully visible and one displayed low figure lacks clear association.
Regulatory and clinical notes
Both providers state treatment is subject to a licensed clinician determining medical appropriateness. Each site references compounded medications; Enhance MD explicitly notes compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. BreezeMeds notes medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Comparison table
| Criteria | Enhance MD | BreezeMeds |
|---|---|---|
| Semaglutide starting price | Semaglutide from $49 first month | Semaglutide injection from $199/mo |
| Tirzepatide starting price | Tirzepatide from $99 first month | Tirzepatide injection from $299 |
| Oral GLP-1 options | Not listed | Oral semaglutide and oral tirzepatide displayed from $399 |
| Pricing model | Flat-rate pricing; same price at every dose, no escalation | Starting-at prices shown; some fees and billing commitments not fully visible |
| Transparency notes | Ongoing flat rate may be higher after introductory month; not always prominently published | Some offers lack clear product association; eligibility and terms advised |
| Regulatory note | Compounded medications not FDA-approved and not reviewed by FDA for safety, effectiveness or quality | Medication-specific approval status must be confirmed; branded and compounded products not interchangeable |
How intake, shipping, and eligibility differ
Enhance MD positions itself as a direct-pay telehealth platform with clinician-directed prescribing and a 10,000+ patient treated claim. BreezeMeds emphasizes online intake, personalized plans, and discreet home delivery but advises confirming eligibility, medication selection, total cost, renewal terms, and state availability before enrollment. Both platforms require clinician review and state-based considerations may apply.
Choosing between Enhance MD and BreezeMeds
Enhance MD vs BreezeMeds comes down to introductory cost and product format. Enhance MD offers the lowest advertised first-month prices and a flat-rate claim that removes dose-based escalation. BreezeMeds lists higher starting prices but shows both injectable and oral GLP-1 options and highlights discreet shipping and personalized plans; however some pricing details and a $169 figure need confirmation on product association.
Choose Enhance MD if…
- You prioritize the lowest first-month cost for semaglutide or tirzepatide and a flat-rate pricing model that claims no escalation with dose.
- You want both semaglutide and tirzepatide available on the same platform and value an explicit low-entry price point.
Choose BreezeMeds if…
- You need injectable and oral GLP-1 formats on offer and will confirm product-level pricing, eligibility, renewal terms, and state availability before enrolling.
For the core question of Enhance MD vs BreezeMeds, Enhance MD is the lower-cost entry with flat-rate claims; BreezeMeds lists broader format options and higher starting prices with some pricing details requiring confirmation.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →